NO20035668D0 - Antitumorformuleringer av tioxantenon - Google Patents

Antitumorformuleringer av tioxantenon

Info

Publication number
NO20035668D0
NO20035668D0 NO20035668A NO20035668A NO20035668D0 NO 20035668 D0 NO20035668 D0 NO 20035668D0 NO 20035668 A NO20035668 A NO 20035668A NO 20035668 A NO20035668 A NO 20035668A NO 20035668 D0 NO20035668 D0 NO 20035668D0
Authority
NO
Norway
Prior art keywords
thioxanthenone
tumor
formulations
tumor formulations
Prior art date
Application number
NO20035668A
Other languages
English (en)
Inventor
Ross Blundell
Edward James Baker
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO20035668D0 publication Critical patent/NO20035668D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20035668A 2001-06-28 2003-12-18 Antitumorformuleringer av tioxantenon NO20035668D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0115893.0A GB0115893D0 (en) 2001-06-28 2001-06-28 Formulations
PCT/GB2002/003012 WO2003002202A1 (en) 2001-06-28 2002-06-28 Antitumoral formulations of thioxanthenone

Publications (1)

Publication Number Publication Date
NO20035668D0 true NO20035668D0 (no) 2003-12-18

Family

ID=9917582

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035668A NO20035668D0 (no) 2001-06-28 2003-12-18 Antitumorformuleringer av tioxantenon

Country Status (22)

Country Link
US (1) US20050176619A1 (no)
EP (1) EP1406699A1 (no)
JP (1) JP2004536099A (no)
KR (1) KR20040030709A (no)
CN (1) CN1520325A (no)
AR (1) AR034621A1 (no)
BG (1) BG108459A (no)
BR (1) BR0210671A (no)
CA (1) CA2451195A1 (no)
CZ (1) CZ20033434A3 (no)
EE (1) EE200400041A (no)
GB (1) GB0115893D0 (no)
HR (1) HRP20031048A2 (no)
HU (1) HUP0402039A2 (no)
IL (1) IL159206A0 (no)
IS (1) IS7070A (no)
MX (1) MXPA03012064A (no)
NO (1) NO20035668D0 (no)
PL (1) PL367636A1 (no)
RU (1) RU2003136086A (no)
SK (1) SK15492003A3 (no)
WO (1) WO2003002202A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2503719T3 (es) * 2005-02-11 2014-10-07 Immunogen, Inc. Procedimiento para preparar conjugados de anticuerpos y de maitansinoides
WO2014081715A1 (en) * 2012-11-20 2014-05-30 Vita Naturale, Llc Compositions and methods for their dermatological use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5346917A (en) * 1991-06-10 1994-09-13 Sterling Winthrop Inc. Thioxanthenone antitumor agents
US5665760A (en) * 1995-09-18 1997-09-09 Sanofi Winthrop, Inc. Lyophilized thioxanthenone antitumor agents
US20030022920A1 (en) * 2001-06-19 2003-01-30 Christoph Ullmer 1-Methyl-4- (3-ethoxy-9H-thioxanthene-9-ylidene) -piperidine and its use as 5-HT2B/H1 receptor antagonist

Also Published As

Publication number Publication date
IS7070A (is) 2003-12-11
CN1520325A (zh) 2004-08-11
US20050176619A1 (en) 2005-08-11
PL367636A1 (en) 2005-03-07
BG108459A (en) 2005-02-28
HRP20031048A2 (en) 2004-04-30
WO2003002202A1 (en) 2003-01-09
CA2451195A1 (en) 2003-01-09
CZ20033434A3 (cs) 2004-08-18
RU2003136086A (ru) 2005-05-27
KR20040030709A (ko) 2004-04-09
JP2004536099A (ja) 2004-12-02
HUP0402039A2 (hu) 2005-01-28
EE200400041A (et) 2004-04-15
IL159206A0 (en) 2004-06-01
SK15492003A3 (sk) 2004-06-08
EP1406699A1 (en) 2004-04-14
GB0115893D0 (en) 2001-08-22
AR034621A1 (es) 2004-03-03
BR0210671A (pt) 2004-10-13
MXPA03012064A (es) 2004-03-26

Similar Documents

Publication Publication Date Title
FR20C1039I2 (fr) Derives de l'uk-2a
NO20043110L (no) Direkte komprimerbare formuleringer av azitromycin
DE50209252D1 (de) Distraktionsvorrichtung
NO20033556L (no) Farmasöytiske formuleringer
NO20040125L (no) Enterale formuleringer
IS2325B (is) Örgerðar samsetningar epleróns
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
ATE319451T1 (de) Tetrahydrochinolin-derivate
ATE312827T1 (de) 3-substituierte-4-pyrimidonderivate
DK1414409T3 (da) Stabiliseret oral suspensionsformulering
NO20034127L (no) Forbedring av aromainneholdende bestanddeler
NO20021834L (no) Orale formuleringer av anti-tumorforbindelser
NO20044916L (no) Preparater av sulfinylacetamid
NO20033737D0 (no) PEG-konjugater av IIGT-NK4
NO20014256D0 (no) Fremstilling av immunstimulerende forbindelse
FI20010558A (fi) Kappaleiden paikannus
NO20041968L (no) Anvendelse av cystationin
ITTO20020789A1 (it) Formulazione solida
NO20015634D0 (no) Fremgangsmåte for tilveiebringelse av tjenester
IS6933A (is) Veirueyðandi samsetningar
DE60223031D1 (de) Arylpiperazin gebundene tetrahydroindolonderivate
DE60216881D1 (de) Schlupfbegrenztes Differential
NO20016151D0 (no) Fremstilling av substituerte piperidin-4-oner
NO20035668D0 (no) Antitumorformuleringer av tioxantenon
PT1392670E (pt) Derivados substituidos de c-furan-2-il-metilamina e c-tiofen-2-il-metilamina

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application